NEIDL in the News
Raising Ebola with Elke Muhlberger (360 Video)
Original article from: STAT posted on October 20, 2017. by Hyacinth Empinado Research on dangerous pathogens like Ebola takes place inside highly secure biosafety level-4 (BSL-4) labs. Elke Mühlberger, a researcher at the National Emerging Diseases Laboratory at Boston University, takes you as close to Ebola as you’ll ever get and... More
BU Annual Giving Society Webinar: A Conversation with Dr. Ronald Corley
The BU Annual Fund Leadership Giving Society presents a conversation with Dr. Ronald Corley, professor and chair of the microbiology at the BU School of Medicine and director of the National Emerging Infectious Diseases Laboratories (NEIDL).
After 15 years, Deadly Disease Research Lab nears Approval in Boston
Original article from Boston 25 News. May 30, 2017 BOSTON - A lab to study deadly diseases like Ebola and bubonic plague is just one vote away from approval in the heart of Boston. Supporters say it will speed the development of new vaccines and cures. But after 15 year of... More
Advances in Ebola Diagnosis and Treatment
Original article from WCAI by Heather Goldstone May 22, 2017 Ebola is back. The virus killed more than 11,000 people between 2014 and 2016. It was the largest Ebola outbreak ever documented. Now, health officials say there’s a new outbreak in the Democratic Republic of Congo. Officials are reporting four deaths and... More
You Can’t Bomb Ebola’: How Nations Should Respond To the Next Pandemic
Original article in Time Health Magazine - Alexandra Sifferlin May 03, 2017 The Ebola outbreak of 2014 infected more than 28,000 people in West Africa and killed more than 11,000. It also exposed gaps in the world's ability to respond to epidemics of infectious diseases. Are we more prepared now to respond... More
How do We Deal with Unknown Diseases? – Dr. Dennis Carroll
Dr Dennis Carroll is Director of the Emerging Threats Program at the U.S. Agency for International Development. We spoke to him at EIDA2Z about the current approach to tackling emerging diseases – and how we need to change it.
New Report Charts Ways to Expedite Research During Epidemics
Original article from: Scientific American posted on April 12, 2017. by Helen Branswell When the largest Ebola outbreak in history exploded across West Africa in 2014, public health authorities raced to test experimental vaccines and drugs they hoped would quell the massive epidemic. But the trials process was too slow, and in... More
NEIDL Researchers Present Case for Next-Level Research
Original article from: BU Today posted on March 7, 2017. by Art Jahnke Infectious disease experts and administrators from Boston University told the Boston Biosafety Committee (BBC) on Monday night that the ability to conduct research at Biosafety Level 4 (BSL-4) at BU’s National Emerging Infectious Diseases Laboratory (NEIDL) would speed... More
Boston Public Health Commission to Consider NEIDL Research Request Tonight
Original article from: BU Today posted on March 6, 2017. by Sara Rimer The Boston Public Health Commission will hold a public meeting this evening, Monday, March 6, to discuss a request by Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) for permission to conduct research at Biosafety Level 4 (BSL-4). More
Blood Test May Predict Who Lives or Dies with Ebola
Original article from: BU Today posted on January 23, 2017. by Barbara Moran In 2014, Ebola exploded across western Africa. It was the worst outbreak of the virus in recorded history, killing more than 11,000 people before it sputtered out in early 2016. In the Republic of Guinea, the epicenter of... More
Bring on the Ebola Research
Original article from: Boston Globe posted on December 29, 2016. by Dante Ramos For humanity to conquer Ebola and other deadly diseases, we need the right combination of scientists to study them from every possible angle. Where’s that more likely to happen — in a state-of-the-art biolab amid the world’s deepest... More
BU Biolab Gets Approval for Research on Deadliest Pathogens
Original article from: Boston Globe posted on December 24, 2016. by Evan Allen & Felicia Gans The Centers for Disease Control and Prevention has approved a Biosafety Level 4 laboratory to operate on Boston University’s medical campus in the South End, according to the Boston Public Health Commission. Scientists in the National... More
Zika virus in Nicaragua with Eva Harris, PhD, at EIDA2Z 2016
Video Courtesy of American Society for Microbiology Eva Harris, PhD, University of California, Berkley, is interviewed by Vincent Racaniello, PhD, Columbia University, New York, about the status of Zika virus in Nicaragua. Harris has developed a multidisciplinary approach to study the molecular virology, pathogenesis, immunology, epidemiology, clinical aspects, and control... More
Emergency Response Exercise to be Conducted November 10, 2016
FOR IMMEDIATE RELEASE: NOVEMBER 10, 2016 Contact: Colin Riley (617) 353-5386, criley@bu.edu (Boston) – On Thursday, November 10, between 9 a.m.- noon Boston University (BU) will conduct an emergency response exercise at the National Emerging Infectious Diseases Laboratories (NEIDL) located at 620 Albany Street. This simulation is part of the NEIDL’s ongoing... More
The 9 Deadliest Viruses on Earth
Original article from: Live Science posted on October 27, 2016. by Anne Harding Humans have been battling viruses since before our species had even evolved into its modern form. For some viral diseases, vaccines and antiviral drugs have allowed us to keep infections from spreading widely, and have helped sick people... More
This Week in Virology: Partnerships Not Parachutes
Hosts: Vincent Racaniello, Alan Dove, and Paul Duprex Guests: Ralph Baric, Felix Drexler, Marion Koopmans, and Stacey Schultz-Cherry From the EIDA2Z conference at Boston University, Vincent, Alan and Paul meet up with Ralph Baric, Felix Drexler, Marion Koopmans, Stacey Schultz-Cherry to talk about discovering, understanding, protecting, and collaborating on emerging infectious diseases. Become... More
How would we deal with a global outbreak? – Sir Roy Anderson
Sir Roy Anderson is a Professor at Imperial College London and the Director of the Centre for Neglected Tropical Disease Research. He told us about the need for an institute combining governments, scientists and industry for rapid action in the case of a global pandemic.
Tuberculosis: A leading cause of death – Prof William Bishai
Professor William Bishai is co-Director of the Johns Hopkins Center for Tuberculosis Research. He spoke to us at EIDA2Z about the importance of global action on tuberculosis – which, despite being the leading infectious cause of death in the world, rarely makes the headlines.
Disease Surveillance in Uganda – Dr Julius Lutwama
Dr Julius Lutwama is a virologist at the Uganda Virus Research Institute. We spoke to him at EIDA2Z about studying viruses and diagnosing disease in the countries where they emerge.
A New Lead on Treatment for Ebola
Original article from: BU Research posted on September 30, 2016. by Elizabeth Dougherty In the book The Hot Zone, author Richard Preston called viruses like Ebola “molecular sharks”—mindless attackers made of almost nothing. Ebola virus, which causes often-fatal hemorrhagic fevers, carries just seven genes, none of which can do much without... More